Toews Corp Bristol Myers Squibb CO Transaction History

Toews Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $781,515 - $873,855	13,500 New	13,500 $783,000
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $458,816 - $543,303	-6,700 Reduced 38.95%	10,500 $755,000
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $91 - $53,788	700 Added 4.24%	17,200 $1.22 Million
Q2 2022 Jul 19, 2022	BUY	$72.62 - $79.98 $806,082 - $887,778	11,100 Added 205.56%	16,500 $1.27 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $331,992 - $398,088	5,400 New	5,400 $394,000
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $364,684 - $425,136	-6,800 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$59.17 - $69.31 $402,356 - $471,308	6,800 New	6,800 $402,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $916,268 - $997,816	-14,800 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $878,232 - $987,751	14,800 New	14,800 $934,000
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $964,258 - $1.09 Million	-16,700 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $959,081 - $1.06 Million	16,700 New	16,700 $1.01 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

Stay updated on Toews Corp with notifications on news.